scorecardresearch
Add as a preferred source on Google
Thursday, April 16, 2026
TopicWeight loss

Topic: weight loss

Mounjaro or Ozempic? What 1st study on Indian cohort found out about efficacy of anti-obesity drugs

Published in Indian Journal of Endocrinology and Metabolism, the study finds that patients without diabetes lost more than double the weight compared to those with the condition.

Genes decide who responds better to GLP-1 drugs. How Nature study findings can change obesity treatment

The study finds specific genetic variants that predict how much weight a person will lose on taking weight loss drugs, & the severity of side effects they experience.

Why US drugmaker Eli Lilly is warning against compounded tirzepatide mixed with vitamin B12

Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.

What happens when use of GLP-1 drugs is stopped? What UK researchers found on tracking patients for a yr

Semaglutide, active ingredient in popular weight-loss drugs, including Ozempic and Wegovy, belongs to the class of medications known as GLP-1 receptor agonists.

As semaglutide goes off patent, weight-loss gold rush begins. Pharma bets big, court case lingers

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic versions of the weight loss drugs in India.

Weight-loss drugs are changing. Here’s what to know about GLP-1s

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them out of reach for many. Pills, which will be cheaper, might change that.

Indian middle class is fed up with being paunchy and plump. Ozempic and Mounjaro are big hits

The instant success of weight loss drugs in India tells us how quickly the country is changing. And for once, the change is for the better.

‘Fat-shamers are now Ozempic-shamers’ — new book takes on India’s weight-loss obsession

The panel discussing Ambrish Mithal and Shivam Vij’s book on obesity and weight loss drugs included Minister of State Jitendra Singh, actor Sharmila Tagore, and HT Media chairperson Shobhana Bhartia.

In Brazil’s São Paulo, armed gangs on the hunt for something more sought-after than gold—Ozempic

Desperation for ‘weight-loss’ drug that’s used to treat type-2 diabetes is real. Break-ins at pharmacies have also been reported in Michigan, US, and Santiago de Copostela, Spain. 

I was a pregnant penguin, see my before-after pics. 66-yr-old’s Ozempic to Mounjaro journey

Weight-loss drugs helped Dimpy Kapoor shed 15 kg and reclaim her life. Ozempic and Mounjaro are a lifeline for diabetics and the obese, but everyone wants in—even those who don’t need them.

On Camera

The Delimitation Dilemma—What Southern politicians should be bargaining for

Instead of fighting the inevitable population shift, southern leaders should seek to integrate migrants and preserve their local influence.

Indian LNG importers accelerate spot market purchases as prices dip

The purchases mark a turnaround after Indian buyers had earlier limited spot buying and canceled tenders because offers were too expensive.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

The world’s in a flux. India must reform, consolidate & build a strong economy

We now live in a world order that will keep shifting. India must use this window. This also means we remain disciplined enough not to be knee-jerked into reacting to what Pakistan sees as its moment in the sun.